Analysis

Vistagen Therapeutics, Inc. (VTGN) Stock Analysis

Vistagen Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VTGN.

websiteVTGN/analysis/VTGN

Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VTGN.

Stock profile

Ticker

VTGN

Asset type

Stock

Market cap

$22.8M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Vistagen Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • VTGN primary listing

Latest Vistagen Therapeutics, Inc. news

Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate

Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social An...

Vistagen Achieves Minimum ICH Safety Exposure Recommendations Across Clinical Program for Fasedienol for the Acute Treatment of Social Anxiety

Vistagen to Participate in Jefferies 2026 Global Healthcare Conference

Vistagen to Participate in Jefferies 2026 Global Healthcare

Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer

Dr. Angelov brings extensive industry experience across multiple therapeutic areas SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vistagen (Nasdaq: VTGN), a

Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Ac...

SOUTH SAN FRANCISCO, Calif., May 12, 2026--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to ...

Research sections

Valuation

Review valuation context for Vistagen Therapeutics, Inc..

Future growth

Review future growth context for Vistagen Therapeutics, Inc..

Past performance

Review past performance context for Vistagen Therapeutics, Inc..

Financial health

Review financial health context for Vistagen Therapeutics, Inc..

Dividend

Review dividend context for Vistagen Therapeutics, Inc..

Management

Review management context for Vistagen Therapeutics, Inc..

Ownership

Review ownership context for Vistagen Therapeutics, Inc..

Other information

Review other information context for Vistagen Therapeutics, Inc..

Community

Review community context for Vistagen Therapeutics, Inc..